miscsubjectsAI governance
Evidence review

PT-141 and Related Peptides for Stimulant Load (Adderall/Amphetamine): Evidence-Graded Review

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-stimulants`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-stimulants

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-stimulants/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-stimulants/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-stimulants/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-stimulants/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Stimulant load (Adderall / amphetamine)

  1. Amphetamines force dopamine and norepinephrine release — borrow focus now.
  2. Sleep, appetite, and gut lining often suffer — less regeneration window.
  3. Chronic load can deplete neurochemistry and stress the gut-brain axis.

Layers:

  • Dopamine system: Forced release → depletion → crash, anhedonia, tolerance.
  • Sleep: Stimulants delay sleep onset and cut deep sleep.
  • Gut: Stimulants stress mucosa; gut inflammation affects mood and cognition.
  • Anxiety: Arousal without calm → jitter, rumination, non-restorative stress.

Why Semax might help you

  1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
  2. What keeps failing: BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.
  3. What Semax is studied to do: Studied for BDNF and neural support — building connections, not sedating symptoms.
  4. Therefore for you: If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.

Why Selank might help you

  1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
  2. Layer breaking down: Anxiety — Arousal without calm → jitter, rumination, non-restorative stress.
  3. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.
  4. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.

Why DSIP might help you

  1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
  2. Layer breaking down: Sleep — Stimulants delay sleep onset and cut deep sleep.
  3. What DSIP is studied to do: Studied for sleep architecture and deep-sleep promotion.
  4. Therefore for you: If that layer is part of your problem, DSIP is discussed because it targets repair (sleep / repair window) — not because it masks pain.

Why PT-141 might help you

  1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
  2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

Why Amphetamine stimulants matters for you

  1. Drug: Amphetamine stimulants
  2. What it does: Forces neurotransmitter release; borrows focus at cost of sleep/gut reserve.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Neural support (Semax), non-benzo calm (Selank), sleep repair window (DSIP) — each targets a stimulant-degeneration layer.

  • Semax → neural / cognitive
  • Selank → anxiety / neurochemistry
  • DSIP → sleep / repair window
  • PT-141 → sexual / CNS arousal

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 4
  • Claims tagged human evidence: 1
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 4

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.3 / 1.00 — low — animal and anecdote heavy

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Bremelanotide (subcutaneous route) - Side effects & dosage (source s2)

FDA-approved use and dosing for HSDD.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

PT-141: a melanocortin agonist for the treatment of sexual dysfunction (source s3)

Early human data on erectogenic effects via central mechanism.

Evidence type: Published research.

Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome (source s9)

Preclinical review on Semax, BDNF, and psychostimulants.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

DSIP reduces amphetamine-induced hyperthermia in mice (source s19)

Mouse study on DSIP and amphetamine hyperthermia.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Peptide components (collapsible embeds)

Semax: BDNF Upregulation · neural / cognitive · semax
{
  "peptide": "semax",
  "regenerative_layer": "neural / cognitive",
  "targets_this_degeneration": "BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.",
  "proposed_regeneration": "Studied for BDNF and neural support — building connections, not sedating symptoms.",
  "evidence_in_ledger": {
    "human_claims": 8,
    "preclinical_claims": 6,
    "anecdote_claims": 68,
    "studies_catalogued": 32
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/semax"
}

Overview Semax is described as a brain peptide that upregulates BDNF. Preclinical Evidence (Rat Studies) In rat hippocampus, a single intranasal dose of Semax (50 μg/kg) produced a maximal 1.4-fold increase in BDNF protein levels, accompanied by increased trkB phosphorylation and mRNA expression (preclinical tier). [Do…

Full semax article →
Selank: Non-Sedating Anxiolytic · anxiety / neurochemistry · selank
{
  "peptide": "selank",
  "regenerative_layer": "anxiety / neurochemistry",
  "targets_this_degeneration": "Chronic stress chemistry, stimulant jitter, non-restorative arousal.",
  "proposed_regeneration": "Studied for anxiolytic pathways without classic benzodiazepine sedation.",
  "evidence_in_ledger": {
    "human_claims": 13,
    "preclinical_claims": 8,
    "anecdote_claims": 60,
    "studies_catalogued": 31
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/selank"
}

Overview Selank is a synthetic heptapeptide derived from tuftsin with reported anxiolytic properties. Human Data A 2008 randomized study compared intranasal Selank to medazepam in 62 patients with generalized anxiety disorder and neurasthenia. Preclinical Data Rat studies show alterations in gene expression related to …

Full selank article →
DSIP: Natural Deep Sleep · sleep / repair window · dsip
{
  "peptide": "dsip",
  "regenerative_layer": "sleep / repair window",
  "targets_this_degeneration": "Lost deep sleep — when growth hormone and tissue repair cycles run.",
  "proposed_regeneration": "Studied for sleep architecture and deep-sleep promotion.",
  "evidence_in_ledger": {
    "human_claims": 9,
    "preclinical_claims": 4,
    "anecdote_claims": 72,
    "studies_catalogued": 26
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/dsip"
}

Evidence-Graded Overview DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide first isolated from rabbit cerebral venous blood. Preclinical studies in multiple species have examined its association with slow-wave sleep. Preclinical Data (Animal and Cell Studies) Rat studies link endogenous DSIP to slow-wave sleep (SWS)…

Full dsip article →

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

stimulants · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 4 sources · swipe →chain cd70697cd3e6 · verify chain · provenance
Evidence ledger 4 · tier-ranked · API
preclinical
Semax increases BDNF and can augment psychostimulant effects on dopamine release in animal models.
sources: s9
preclinical
DSIP reduced amphetamine-induced hyperthermia in mice at specific doses.
sources: s19
mechanistic
PT-141 (bremelanotide) activates melanocortin receptors to promote central sexual arousal and dopamine release in relevant brain areas.
sources: s3
humanlow confidence
PT-141 received FDA approval for HSDD based on randomized placebo-controlled trials showing improved desire scores.
sources: s2
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 01:07
PT-141 and Related Peptides for Stimulant Load (Adderall/Amphetamine): Evidence-Graded Review · 4 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: PT 141 for Stimulants
Slug: pt-141-stimulants
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"multi_stack","condition":"Stimulant load (Adderall / amphetamine)","condition_key":"adderall-stimulant","primary_peptide":null,"peptides_in_scope":[{"id":"semax","name":"Semax"},{"id":"selank","name":"Selank"},{"id":"dsip","name":"DSIP"},{"id":"pt-141","name":"PT-141"}],"drugs_in_scope":["a
it output
{
  "slug": "pt-141-stimulants",
  "title": "PT-141 and Related Peptides for Stimulant Load (Adderall/Amphetamine): Evidence-Graded Review",
  "body": "## What's breaking down if you have Stimulant load (Adderall / amphetamine)\n\nAmphetamines force dopamine and norepinephrine release. This borrows focus in the moment but can leave systems depleted.\n\nSleep, appetite, and gut lining often suffer. Less regeneration window follows each dose.\n\nChronic load can deplete neurochemistry and stress the gut-brain axis.\n\nFour main layers show the pattern:\n\n- Dopamine system: Forced release leads to depletion, crash, anhedonia, and tolerance.\n- Sleep: Stimulants delay onset and cut deep sleep stages.\n- Gut: Mucosa faces stress; inflammation there can affect mood and cognition.\n- Anxiety: Arousal without calm produces jitter, rumination, and non-restorative stress.\n\nBreakdown outruns repair in these layers when use continues without targeted support.\n\n## Why Semax might help you\n\n1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.\n2. What keeps failing: BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\n3. What Semax is studied to do: Studied for BDNF and neural support — building connections, not sedating symptoms.\n4. Therefore for you: If that layer is part of your problem, Semax is discussed because it
69637f710330fc3f
Machine verification: /api/articles/pt-141-stimulants/contributions
Ask this article · 6 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "Semax increases BDNF and can augment psychostimulant effects on dopamine release in animal models."?
ask pt-141-stimulants claim c2 · paste includes §SELF
What does the ledger say about this (preclinical tier): "DSIP reduced amphetamine-induced hyperthermia in mice at specific doses."?
ask pt-141-stimulants claim c3 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "PT-141 (bremelanotide) activates melanocortin receptors to promote central sexual arousal and dopamine release in relevant brain areas."?
ask pt-141-stimulants claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "PT-141 received FDA approval for HSDD based on randomized placebo-controlled trials showing improved desire scores."?
ask pt-141-stimulants claim c4 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about PT-141 and Related Peptides for Stimulant Load (Adderall/Amphetamine): Evidence-Graded Review — and what would you need me to tell you first?
ask pt-141-stimulants condition gaps · paste includes §SELF
What good and bad outcomes are documented for PT-141 and Related Peptides for Stimulant Load (Adderall/Amphetamine): Evidence-Graded Review (studies vs anecdotes)?
ask pt-141-stimulants good bad experiences · paste includes §SELF
pt-141-stimulants · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 20520 tokens · $0 · 2 models
chain head 0a699f8c2914ac34
write grok/grok-4.3 · 2026-06-30 01:07 · 20520 tok · be215e615c1d
voxel_divide owner · 2026-07-17 02:41 · tokens unrecorded · 0a699f8c2914
verify chain →
Live ledger · 23 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 19:42
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 19:25
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 19:25
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 16:37
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 14:24
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 13:47
view full ledger & cards →
REST + ledger
read GET /api/articles/pt-141-stimulants · GET /api/articles/pt-141-stimulants?format=post (the editable body)
create/replace POST /api/articles/pt-141-stimulants · PUT /api/articles/pt-141-stimulants (replace, keeps revision) · PATCH /api/articles/pt-141-stimulants (merge)
delete DELETE /api/articles/pt-141-stimulants
writes need header x-terminal-key
LLM bundle GET /api/articles/pt-141-stimulants/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim pt-141-stimulants|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →